These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 4792112)
1. Studies on lankacidin-group (T-2636) antibiotics. VII. Structure-activity relationships of lankacidin-group antibiotics. Harada S; Yamazaki T; Hatano K; Tsuchiya K; Kishi T J Antibiot (Tokyo); 1973 Nov; 26(11):647-57. PubMed ID: 4792112 [No Abstract] [Full Text] [Related]
2. [Antibacterial properties of lincomycin in vitro and its chemotherapeutic activity]. Shorin VA; Pevzner NS Antibiotiki; 1968 Sep; 13(9):810-5. PubMed ID: 4387685 [No Abstract] [Full Text] [Related]
3. Quantitative structure--activity relationships in leucomycin and lincomycin antibiotics. Martin YC; Lynn KR J Med Chem; 1971 Dec; 14(12):1162-6. PubMed ID: 5000561 [No Abstract] [Full Text] [Related]
4. Studies on lankacidin-group (T-2636) antibiotics. V. Chemical structures of lankacidin-group antibiotics. 1. Harada S; Kishi T Chem Pharm Bull (Tokyo); 1974 Jan; 22(1):99-108. PubMed ID: 4833376 [No Abstract] [Full Text] [Related]
5. Antitumor and immunosuppressive activities of lankacidin-group antibiotics: structure-activity relationships. Oostu K; Matsumoto T; Harada S; Kishi T Cancer Chemother Rep; 1975; 59(5):919-28. PubMed ID: 1148 [TBL] [Abstract][Full Text] [Related]
6. Studies on lankacidin-group (T-2636) antibiotics. VI. Chemical structures of lankacidin-group antibiotics. II. Harada S Chem Pharm Bull (Tokyo); 1975 Oct; 23(10):2201-10. PubMed ID: 1212749 [No Abstract] [Full Text] [Related]
7. Relationship of structures and microbiological activities of the 16-membered macrolides. Omura S; Tishler M J Med Chem; 1972 Oct; 15(10):1011-5. PubMed ID: 4627057 [No Abstract] [Full Text] [Related]
8. Side chain modifications in lankacidin group antibiotics. McFarland JW; Pirie DK; Retsema JA; English AR Antimicrob Agents Chemother; 1984 Feb; 25(2):226-33. PubMed ID: 6370129 [TBL] [Abstract][Full Text] [Related]
12. A54145 a new lipopeptide antibiotic complex: microbiological evaluation. Counter FT; Allen NE; Fukuda DS; Hobbs JN; Ott J; Ensminger PW; Mynderse JS; Preston DA; Wu CY J Antibiot (Tokyo); 1990 Jun; 43(6):616-22. PubMed ID: 2380110 [TBL] [Abstract][Full Text] [Related]
13. Maridomycin, a new macrolide antibiotic: in vivo antibacterial activity of 9-propionylmaridomycin. Kondo M; Ishifuji K; Tsuchiya K; Goto S; Kuwahara S Antimicrob Agents Chemother; 1973 Aug; 4(2):156-9. PubMed ID: 4790936 [TBL] [Abstract][Full Text] [Related]
14. Chemistry and biology of the polyene macrolide antibiotics. Hamilton-Miller JM Bacteriol Rev; 1973 Sep; 37(3):166-96. PubMed ID: 4202146 [No Abstract] [Full Text] [Related]
15. Topochemical approach in studies of the structure-activity relation: enantio-enniatin B. Shenyakin MM; Ovchinnikov YA; Ivanov VT; Evstratov AV Nature; 1967 Jan; 213(5074):412-3. PubMed ID: 4961750 [No Abstract] [Full Text] [Related]
16. Design, synthesis, and antimicrobial activity of 6-O-substituted ketolides active against resistant respiratory tract pathogens. Or YS; Clark RF; Wang S; Chu DT; Nilius AM; Flamm RK; Mitten M; Ewing P; Alder J; Ma Z J Med Chem; 2000 Mar; 43(6):1045-9. PubMed ID: 10737737 [No Abstract] [Full Text] [Related]